Vitamin K and vitamin D status: associations with inflammatory markers in the Framingham Offspring Study.

In vitro data suggest protective roles for vitamins K and D in inflammation. To examine associations between vitamins K and D and inflammation in vivo, the authors used multiple linear regression analyses, adjusted for age, sex, body mass index, triglyceride concentrations, use of aspirin, use of lipid-lowering medication, season, menopausal status, and hormone replacement therapy. Participants were from the Framingham Offspring Study (1997-2001; n = 1,381; mean age = 59 years; 52% women). Vitamin K status, measured by plasma phylloquinone concentration and phylloquinone intake, was inversely associated with circulating inflammatory markers as a group and with several individual inflammatory biomarkers (p < 0.01). Percentage of undercarboxylated osteocalcin, a functional measure of vitamin K status, was not associated with overall inflammation but was associated with C-reactive protein (p < 0.01). Although plasma 25-hydroxyvitamin D was inversely associated with urinary isoprostane concentration, an indicator of oxidative stress (p < 0.01), overall associations between vitamin D status and inflammation were inconsistent. The observation that high vitamin K status was associated with lower concentrations of inflammatory markers suggests that a possible protective role for vitamin K in inflammation merits further investigation.

[1]  S. Booth,et al.  Role of vitamin K in the regulation of calcification , 2007 .

[2]  J. Hansen,et al.  Serum osteoprotegerin is inversely associated with carotid plaque echogenicity in humans. , 2005, Atherosclerosis.

[3]  F. Hu,et al.  Phylloquinone intake and risk of cardiovascular diseases in men. , 2007, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[4]  J. Myśliwska,et al.  Interleukin 6 polymorphism corresponds to the number of severely stenosed coronary arteries. , 2006, European cytokine network.

[5]  C. Christiansen,et al.  Radiographic measure of aorta calcification is a site‐specific predictor of bone loss and fracture risk at the hip , 2006, Journal of internal medicine.

[6]  R. D'Agostino,et al.  Relations of inflammation and novel risk factors to valvular calcification. , 2006, The American journal of cardiology.

[7]  R. D'Agostino,et al.  Association of educational level with inflammatory markers in the Framingham Offspring Study. , 2006, American journal of epidemiology.

[8]  G. Tenderich,et al.  Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. , 2006, The American journal of clinical nutrition.

[9]  Peter Libby,et al.  Inflammation and cardiovascular disease mechanisms. , 2006, The American journal of clinical nutrition.

[10]  Yusuke Ohsaki,et al.  Vitamin K Suppresses Lipopolysaccharide-Induced Inflammation in the Rat , 2006, Bioscience, biotechnology, and biochemistry.

[11]  D. Kiel,et al.  Bone loss and the progression of abdominal aortic calcification over a 25 year period: The Framingham heart study , 2001, Calcified Tissue International.

[12]  B. Riggs,et al.  The role of the immune system in the pathophysiology of osteoporosis , 2005, Immunological reviews.

[13]  C. Mathieu,et al.  Immunoregulation by 1,25-dihydroxyvitamin D3: Basic concepts , 2005, The Journal of Steroid Biochemistry and Molecular Biology.

[14]  R. Koerfer,et al.  Putting cardiovascular disease and vitamin D insufficiency into perspective , 2005, British Journal of Nutrition.

[15]  A. Lin,et al.  Antioxidative Effect of Vitamin D3 on Zinc‐Induced Oxidative Stress in CNS , 2005, Annals of the New York Academy of Sciences.

[16]  M. Fukunaga,et al.  Menaquinone-7 regulates the expressions of osteocalcin, OPG, RANKL and RANK in osteoblastic MC3T3E1 cells. , 2005, International journal of molecular medicine.

[17]  G. Vigna,et al.  Testosterone replacement, cardiovascular system and risk factors in the aging male. , 2005, Journal of endocrinological investigation.

[18]  M. Mastropasqua,et al.  Cardiovascular disease and osteoporosis. , 2005, Journal of endocrinological investigation.

[19]  M. Holick Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. , 2004, The American journal of clinical nutrition.

[20]  K. Özoran,et al.  The Effects of Calcitriol Therapy on Serum Interleukin-1, Interleukin-6 and Tumour Necrosis Factor-α Concentrations in Post-menopausal Patients with Osteoporosis , 2004, The Journal of international medical research.

[21]  D. Kiel,et al.  Associations between vitamin K biochemical measures and bone mineral density in men and women. , 2004, The Journal of clinical endocrinology and metabolism.

[22]  P. Wilson,et al.  Dietary phylloquinone intake as a potential marker for a heart-healthy dietary pattern in the Framingham Offspring cohort. , 2004, Journal of the American Dietetic Association.

[23]  L. Hofbauer,et al.  Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases. , 2004, JAMA.

[24]  H. Bischoff-Ferrari,et al.  Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults. , 2004, The American journal of medicine.

[25]  Kwan Tat Steeve,et al.  IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology. , 2004 .

[26]  S. Kwan Tat,et al.  IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology. , 2004, Cytokine & growth factor reviews.

[27]  Y. Asano,et al.  Vitamin K2 inhibits glucocorticoid-induced bone loss partly by preventing the reduction of osteoprotegerin (OPG) , 2004, Journal of Bone and Mineral Metabolism.

[28]  R. Detrano,et al.  Calcification in atherosclerosis: Bone biology and chronic inflammation at the arterial crossroads , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[29]  M. Gannagé-Yared,et al.  Effects of a short-term calcium and vitamin D treatment on serum cytokines, bone markers, insulin and lipid concentrations in healthy post-menopausal women , 2003, Journal of endocrinological investigation.

[30]  Hong Wang,et al.  Novel Role of Vitamin K in Preventing Oxidative Injury to Developing Oligodendrocytes and Neurons , 2003, The Journal of Neuroscience.

[31]  E. Benjamin,et al.  Obesity and Systemic Oxidative Stress: Clinical Correlates of Oxidative Stress in The Framingham Study , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[32]  L. Hofbauer,et al.  Increased osteoprotegerin serum levels in men with coronary artery disease. , 2003, The Journal of clinical endocrinology and metabolism.

[33]  F. Cosman,et al.  Cytokine profile in patients with multiple sclerosis following vitamin D supplementation , 2003, Journal of Neuroimmunology.

[34]  D. Kiel,et al.  Dietary and nondietary determinants of vitamin K biochemical measures in men and women. , 2002, The Journal of nutrition.

[35]  B. Dawson-Hughes,et al.  Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. , 2002, Bone.

[36]  K. Preissner,et al.  RANK ligand and osteoprotegerin: paracrine regulators of bone metabolism and vascular function. , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[37]  William Maloney,et al.  Receptor Activator of NF-κB and Osteoprotegerin Expression by Human Microvascular Endothelial Cells, Regulation by Inflammatory Cytokines, and Role in Human Osteoclastogenesis* , 2001, The Journal of Biological Chemistry.

[38]  K. Ikeda,et al.  Immunological Characterization of Circulating Osteoprotegerin/Osteoclastogenesis Inhibitory Factor: Increased Serum Concentrations in Postmenopausal Women with Osteoporosis , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[39]  C. Tetta,et al.  Calcitriol modulates in vivo and in vitro cytokine production: a role for intracellular calcium. , 1998, Kidney international.

[40]  C. Gundberg,et al.  Vitamin K status and bone health: an analysis of methods for determination of undercarboxylated osteocalcin. , 1998, The Journal of clinical endocrinology and metabolism.

[41]  K Yano,et al.  Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[42]  R. Heaney,et al.  Vitamin D and its Major Metabolites: Serum Levels after Graded Oral Dosing in Healthy Men , 1998, Osteoporosis International.

[43]  B. Dawson-Hughes,et al.  Nutritional Aspects of Osteoporosis , 1998, Proceedings in the Serono Symposia USA Series.

[44]  P. Wilson,et al.  Plasma 25-hydroxyvitamin D and its determinants in an elderly population sample. , 1997, The American journal of clinical nutrition.

[45]  J. Sadowski,et al.  Determination of vitamin K compounds in plasma or serum by high-performance liquid chromatography using postcolumn chemical reduction and fluorimetric detection. , 1997, Methods in enzymology.

[46]  B. Henderson,et al.  Interleukin 6 production by lipopolysaccharide-stimulated human fibroblasts is potently inhibited by naphthoquinone (vitamin K) compounds. , 1995, Cytokine.

[47]  M. Shiraki,et al.  Vitamin K2 (menatetrenone) inhibits prostaglandin synthesis in cultured human osteoblast-like periosteal cells by inhibiting prostaglandin H synthase activity. , 1993, Biochemical pharmacology.

[48]  A. Kharazmi,et al.  1,25-Dihydroxyvitamin D3 inhibits cytokine production by human blood monocytes at the post-transcriptional level. , 1992, Cytokine.

[49]  P. Allhoff,et al.  The Framingham Offspring Study , 1991 .

[50]  P. Garry,et al.  Phylloquinone in plasma from elderly and young adults: factors influencing its concentration. , 1989, The American journal of clinical nutrition.

[51]  W. Willett,et al.  Reproducibility and validity of a semiquantitative food frequency questionnaire. , 1985, American journal of epidemiology.

[52]  J. Lian,et al.  Osteocalcin: isolation, characterization, and detection. , 1984, Methods in enzymology.

[53]  W. Kannel,et al.  An investigation of coronary heart disease in families. The Framingham offspring study. , 1979, American journal of epidemiology.

[54]  A. Clauss,et al.  Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens , 1957 .

[55]  A. Clauss [Rapid physiological coagulation method in determination of fibrinogen]. , 1957, Acta haematologica.